未登録の方はこちらから登録できます。
TEL．03-5812-5270
FAX．03-3831-0495
E-mail：info@spi-information.com
市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。
当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。
Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies
世界の心血管デバイスパイプライン展望：今後の主な製品と技術の分析
主な心血管デバイスメーカーが、経済や規制の課題に影響を受けていますが、増加する研究開発費、製品パイプラインの縮小や中小企業との競争の激化などの要素は、競争力を保ち、利益を保つべく、これらのメーカーにさらなる圧力を加えています。市場勢力図が絶えず拡大することを考えると、市場に参入する見込みのある主要な心血管のパイプラインデバイスを徹底的に分析することは重要です。本レポートは、今後7年間に市場に参入する見込みのある主要な心血管パイプラインデバイスにおける主要なデータ、情報や分析、また、これらの製品の市場潜在力、市場の範囲、および予想される普及についての情報も提供します。また、既存の競合技術や上市が市場勢力図に与える影響についても特定し、評価します。本レポートは、GlobalData社の業界専門家のチームによる独自のデータベース、一次的および二次的研究、および社内の分析から、データと情報を提供します。
■調査範囲
- 2002〜2009年までの年間市場収益データと2016年までの7年間の予測
- 製品の詳細、特徴、利点や長所などの情報とともに、各パイプライン製品を概説します。
- 他の既存の競合製品と比べた各製品の安全性と有効性プロファイル
- 市場潜在力の予測とともに製品の詳細、適応症の詳細、治験状況における情報を提供します。
- 製品がターゲットとする市場を形成および明確にする動向の評価と分析を提供します。
- 上市や普及に影響を与えると思われるデバイス特有の開発、M&A展望、戦略的提携など、主要なトピックスをカバーします。
- Medtronic社、Cordis Corporation社、St Jude Medical社、Boston Scientific Corporation社、およびAbbott社などの主要企業をカバーします。
目次
Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Global Cardiovascular Devices Market Overview
2.1 Cardiovascular Devices, Global, Revenue ($m), Historic, 2000-2009
2.2 Cardiovascular Devices, Global, Revenue ($m), Forecast, 2009-2016
2.3 Global Cardiovascular Devices Market: Company Shares
3 Cardiac Rhythm Management : Pipeline Landscape
3.1 Cardiac Rhythm Management: Market Overview
3.1.1 Cardiac Rhythm Management, Global, Revenue ($m), Historic, 2000-2009
3.1.2 Cardiac Rhythm Management, Global, Revenue ($m), Forecast, 2009-2016
3.2 Cardiac Rhythm Management: Market Dynamics
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Cardiac Rhythm Management: Technology Landscape
3.3.1 MRI Compatible Cardiac Rhythm Management Devices
3.3.2 EnRhythm MRI SureScan Pacing System
3.3.3 Wireless Cardiac Stimulation Device
3.3.4 Paradym sonR CRT- D
3.4 Cardiac Rhythm Management Pipeline Product Summary
4 Cardiovascular Monitoring and Diagnostic Devices: Pipeline Landscape
4.1 Cardiovascular Monitoring and Diagnostic Devices: Market Overview
4.1.1 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Historic, 2000-2009
4.1.2 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Forecast, 2009-2016
4.2 Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics
4.2.1 Market Drivers
4.3 Cardiovascular Monitoring and Diagnostic Devices: Technology Landscape
4.3.1 Leadless Cardiac Monitoring Device
4.4 Cardiovascular Monitoring and Diagnostic Devices Pipeline Product Summary
5 Cardiovascular Prosthetic Devices: Pipeline Landscape
5.1 Cardiovascular Prosthetic Devices: Market Overview
5.1.1 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Historic, 2000-2009
5.1.2 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Forecast, 2009-2016
5.2 Cardiovascular Prosthetic Devices: Market Dynamics
5.2.1 Market Drivers
5.2.2 Market Restraints
5.3 Cardiovascular Prosthetic Devices: Technology Landscape
5.3.1 AbioCor II
5.3.2 3f Enable Aortic Valve
5.3.3 Perceval S Sutureless Aortic Valve
5.3.4 SAPIEN Transcatheter Heart Valve
5.3.5 Melody Transcatheter Pulmonary Valve
5.4 Cardiovascular Prosthetic Devices Pipeline Product Summary
6 Cardiovascular Surgery: Pipeline Landscape
6.1 Cardiovascular Surgery: Market Overview
6.1.1 Cardiovascular Surgery, Global, Revenue ($ m), Historic, 2000-2009
6.1.2 Cardiovascular Surgery, Global, Revenue ($ m), Forecast, 2009-2016
6.2 Cardiovascular Surgery: Market Dynamics
6.2.1 Market Drivers
6.2.2 Market Restraints
6.3 Cardiovascular Surgery: Technology Landscape
6.3.1 CyberHeart System
6.4 Cardiovascular Surgery Pipeline Product Summary
7 Electrophysiology: Pipeline Landscape
7.1 Electrophysiology: Market Overview
7.1.1 Electrophysiology, Global, Revenue ($ m), Historic, 2000-2009
7.1.2 Electrophysiology, Global, Revenue ($ m), Forecast, 2009-2016
7.2 Electrophysiology: Market Dynamics
7.2.1 Market Drivers
7.2.2 Market Restraints
7.3 Electrophysiology: Technology Landscape
7.3.1 Sensei System for Atrial Fibrillation
7.4 Electrophysiology Pipeline Product Summary
8 Interventional Cardiology: Pipeline Landscape
8.1 Interventional Cardiology: Market Overview
8.1.1 Interventional Cardiology, Global, Revenue ($ m), Historic, 2000-2009
8.1.2 Interventional Cardiology, Global, Revenue ($ m), Forecast, 2009-2016
8.2 Interventional Cardiology: Market Dynamics
8.2.1 Market Drivers
8.2.2 Market Restraints
8.3 Interventional Cardiology: Technology Landscape
8.3.1 Bioabsorbable stents
8.3.2 VestaSync
8.3.3 Combo Bio-engineered Sirolimus Eluting Stent
8.3.4 Intravascular Ultrasound
8.3.5 AMPLATZER PFO Occluder - Migraine
8.4 Interventional Cardiology Pipeline Product Summary
9 Peripheral Vascular Devices: Pipeline Landscape
9.1 Peripheral Vascular Devices: Market Overview
9.1.1 Peripheral Vascular Devices, Global, Revenue ($ m), Historic, 2000-2009
9.1.2 Peripheral Vascular Devices, Global, Revenue ($ m), Forecast, 2009-2016
9.2 Peripheral Vascular Devices: Market Dynamics
9.2.1 Market Drivers
9.2.2 Market Restraints
9.3 Peripheral Vascular Devices: Technology Landscape
9.3.1 ZILVER PTX Drug Eluting Peripheral Stent
9.4 Peripheral Vascular Devices Pipeline Product Summary
10 Appendix
10.1 Abbreviations
10.2 Definitions
10.2.1 Cardiovascular Devices
10.2.2 Cardiac Rhythm Management
10.2.3 Cardiovascular Monitoring and Diagnostic Devices
10.2.4 Cardiovascular Prosthetic Device
10.2.5 Cardiovascular Surgery
10.2.6 Electrophysiology
10.2.7 Interventional Cardiology
10.2.8 Peripheral Vascular Devices
10.3 Research Methodology
10.4 Secondary Research
10.5 Primary Research
10.6 Models
10.7 Forecasts
10.8 Expert Panels
10.9 GlobalData Consulting
10.10 Contact Us
10.11 Disclaimer
List of Figures
Figure 1: Cardiovascular Devices, Global, Revenue ($m), 2000-2009
Figure 2: Cardiovascular Devices, Global, Revenue ($m), 2009-2016
Figure 3: Global Cardiovascular Devices Market, Company Shares (%), 2008
Figure 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009
Figure 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016
Figure 6: EnRhythm MRI SureScan pacing system: Features and Benefit Analysis
Figure 7: Wireless Cardiac Stimulation Device: Features and Benefit Analysis
Figure 8: Paradym sonR CRT-D: Features and Benefit Analysis
Figure 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009
Figure 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016
Figure 11: Leadless Cardiac Monitoring Device: Features and Benefit Analysis
Figure 12: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009
Figure 13: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016
Figure 14: AbioCor II: Features and Benefit Analysis
Figure 15: 3f Enable Aortic Valve: Features and Benefit Analysis
Figure 16: Perceval S Sutureless Aortic Valve: Features and Benefit Analysis
Figure 17: SAPIEN Transcatheter Heart Valve: Features and Benefit Analysis
Figure 18: Melody Transcatheter Pulmonary Valve: Features and Benefit Analysis
Figure 19: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009
Figure 20: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016
Figure 21: CyberHeart System: Features and Benefit Analysis
Figure 22: Electrophysiology, Global, Revenue ($ m), 2000-2009
Figure 23: Electrophysiology, Global, Revenue ($ m), 2009-2016
Figure 24: Sensei System for Atrial Fibrillation: Features and Benefit Analysis, 2010
Figure 25: Interventional Cardiology, Global, Revenue ($ m), 2000-2009
Figure 26: Interventional Cardiology, Global, Revenue ($ m), 2009-2016
Figure 27: Abbott Bioabsorbable Everolimus Eluting Coronary Stent: Features and Benefit Analysis, 2010
Figure 28: VestaSync: Features and Benefit Analysis, 2010
Figure 29: Combo Bio-engineered Sirolimus Eluting Stent: Features and Benefit Analysis, 2010
Figure 30: Comparison of Coronary Angiogram With Intra Vascular Ultrasound Image, 2010
Figure 31: Intra Vascular Ultrasound: Features and Benefit Analysis, 2010
Figure 32: AMPLATZER PFO Occluder-migraine: Features and Benefit Analysis, 2010
Figure 33: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009
Figure 34: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016
Figure 35: ZILVER PTX Drug Eluting Peripheral Stent: Features and Benefit Analysis, 2010
Figure 36: GlobalData Methodology
List of Tables
Table 1: Cardiovascular Devices, Global, Revenue ($ m), 2000-2009
Table 2: Cardiovascular Devices, Global, Revenue ($ m), 2009-2016
Table 3: Global Cardiovascular Devices Market, Company Shares, Revenue ($ m), 2008
Table 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009
Table 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016
Table 6: Paradym sonR CRT defibrillator, Europe, Revenue ($ m), 2009-2016
Table 7: Global Cardiac Rhythm Management Pipeline Product Summary - I
Table 8: Global Cardiac Rhythm Management Pipeline Product Summary - II
Table 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009
Table 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016
Table 11: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - I
Table 12: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - II
Table 13: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - III
Table 14: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009
Table 15: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016
Table 16: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - I
Table 17: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - II
Table 18: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - III
Table 19: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - IV
Table 20: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - V
Table 21: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009
Table 22: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016
Table 23: Global Cardiovascular Surgery Pipeline Product Summary - I
Table 24: Global Cardiovascular Surgery Pipeline Product Summary - II
Table 25: Electrophysiology, Global, Revenue ($ m), 2000-2009
Table 26: Electrophysiology, Global, Revenue ($ m), 2009-2016
Table 27: Global Electrophysiology Pipeline Product Summary -I
Table 28: Global Electrophysiology Pipeline Product Summary -II
Table 29: Interventional Cardiology, Global, Revenue ($ m), 2000-2009
Table 30: Interventional Cardiology, Global, Revenue ($ m), 2009-2016
Table 31: Global Interventional Cardiology Pipeline Product Summary - I
Table 32: Global Interventional Cardiology Pipeline Product Summary - II
Table 33: Global Interventional Cardiology Pipeline Product Summary - III
Table 34: Global Interventional Cardiology Pipeline Product Summary - IV
Table 35: Global Interventional Cardiology Pipeline Product Summary - V
Table 36: Global Interventional Cardiology Pipeline Product Summary - VI
Table 37: Global Interventional Cardiology Pipeline Product Summary - VII
Table 38: Global Interventional Cardiology Pipeline Product Summary - VIII
Table 39: Global Interventional Cardiology Pipeline Product Summary - IX
Table 40: Global Interventional Cardiology Pipeline Product Summary - X
Table 41: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009
Table 42: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016
Table 43: Global Peripheral Vascular Devices Pipeline Product Summary - I
Table 44: Global Peripheral Vascular Devices Pipeline Product Summary - II
Table 45: Global Peripheral Vascular Devices Pipeline Product Summary - III
Table 46: Global Peripheral Vascular Devices Pipeline Product Summary - IV
Table 47: Global Peripheral Vascular Devices Pipeline Product Summary - V
発刊日
2010/01/29
体裁
PDF / 111ページ
販売価格
2,000USD
発行
GlobalData
備考
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
関連カテゴリ
購入・お問い合わせ
